PE  1315 Capital

http://www.1315capital.com/





     Office Locations:

2929 Walnut Street, Suite 1240
Philadelphia, PA 19104
Phone: 215-662-1315

 

Stages:

  • Expansion
  • Growth


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    1315 Capital is a private investment firm that provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare service companies. The firm targets $10 to $25 million investments in commercial healthcare businesses that have the potential to scale to approximately $100 million of revenue, a highly attractive level for acquisition or to access the public markets.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Adele C. Oliva Co-founder & Partner
    Brian Schwenk CFO
    Craig Matturro Associate
    Edward Chan Principal
    Ian B. Li Associate

     

    Portfolio companies include:


      Encore Dermatology
        web link


      Innovative Health
        web link


      Interphase Medical Equipment
        web link


      JDS Therapeutics


      Onkos Surgical
        web link


     

    Recent News: